EARLY CONVERSION TO A CNI-FREE IMMUNOSUPPRESSION WITH SRL AFTER RENAL TX - LONGTERM DATA OF A MULTICENTER TRIAL

被引：0
|
作者：
Andrassy, Joachim [1 ]
Guba, Markus [1 ]
Habicht, Antje [2 ]
Pascher, Andreas [3 ]
Heller, Katharina [4 ]
Banas, Bernhard [5 ]
Hakenberg, Oliver [6 ]
Vogel, Thomas [7 ]
Werner, Jens [1 ]
Kauke, Teresa [1 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Univ Hosp Grosshadern, Dept Surg, Munich, Germany
[2] Lmu, Transplant Ctr, Munich, Germany
[3] Charite, Dept Surg, Campus Virchow Clin, Berlin, Germany
[4] Univ Erlangen Nurnberg, Dept Med, Div Nephrol, Erlangen, Germany
[5] Univ Med Ctr, Dept Internal Med Nephrol & Transplantat 2, Regensburg, Germany
[6] Univ Rostock, Dept Urol, Rostock, Germany
[7] Univ Munster, Dept Surg, Munster, Germany
来源：
TRANSPLANT INTERNATIONAL | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
OS161
引用
收藏
页码：63 / 63
页数：1
相关论文
共 50 条
  • [21] Immune-Monitoring of Alloreactive Memory/Effector T-Cell Alloresponse for Selection of CNI-Free Immunosuppression in Renal Tranplantation
    Bestard, O.
    Cruzado, J. M.
    Casssis, L.
    Franquesa, M.
    Cantarell, C.
    Totras, J.
    Goma-i-Freixanet, M.
    Sawitzki, B.
    Volk, H. D.
    Reinke, P.
    Grinyo, J. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 395 - 395
  • [22] Conversion from calcineurin-inhibitor (CNI) based immunosuppression to Sirolimus in chronic CNI toxicity after renal transplantation
    Diekmann, F
    Waiser, J
    Einecke, G
    Dragun, D
    Fritsche, L
    Neumayer, HH
    Budde, K
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 364A - 364A
  • [23] Incidence of Rejection after Conversion to Proliferation Signal Inhibitors after Heart Transplantation. Is There any Difference between CNI-Free vs CNI Minimization Regimens?
    Crespo-Leiro, M. G.
    Paniagua-Martin, M. J.
    Marzoa-Rivas, R.
    Barge-Caballero, E.
    Grille-Cancela, Z.
    Pombo-Otero, J.
    Naya-Leira, C.
    Farinas-Garrido, P.
    Garcia-Guimaraes, M.
    Mendez-Eirin, E.
    Castro-Beiras, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S228 - S228
  • [24] CNI-FREE DE NOVO "BOTTOM-UP, ON DEMAND" IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS WITH PREEXISTING RENAL IMPAIRMENT: AN INITIAL EXPERIENCE
    Schnitzbauer, Andreas A.
    Doenecke, Axel
    Sothmann, Johannes
    Loss, Martin
    Farkas, Stefan A.
    Zuelke, Carl
    Scherer, Marcus N.
    Schlitt, Hans J.
    TRANSPLANT INTERNATIONAL, 2009, 22 : 236 - 236
  • [25] An open, single centre, prospective study to investigate a steroid free immunosuppressive regimen for de novo renal transplant recipients followed by a two arm randomisation to a CNI-sparing and a CNI-free maintenance immunosuppression after 3 months
    Oetti, T.
    Descoeudres, B.
    Burkhalter, F.
    Bachmann, A.
    Guerke, L.
    Mihatsch, M. J.
    Dickenmann, M.
    Steiger, J.
    SWISS MEDICAL WEEKLY, 2008, 138 (47-48) : 15S - 15S
  • [26] A Prospective, Randomized, Multicenter Trial of Bela-Based CNI Free and Steroid Withdrawal Immunosuppression: Best Trial Two Year Characterization of Rejection and Renal Function
    Wiseman, A.
    Shields, A. R.
    Alloway, R. R.
    Kaufman, D.
    Leone, J. P.
    Matas, A. J.
    West-Thielke, P.
    Lipscomb, J.
    King, E.
    Woodle, E. S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 953 - 954
  • [27] The BEST Trial: A Prospective Randomized Multicenter Trial of Belatacept-Based CNI- and Corticosteroid-Free Immunosuppression.
    Woodle, E.
    Kaufman, D.
    Shields, A.
    Leone, J.
    Wiseman, A.
    Matas, A.
    West-Thielke, P.
    King, E.
    Alloway, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 290 - 291
  • [28] A Prospective Randomized Multicenter Trial (BEST Trial) of Belatacept-Based CNI- and Corticosteroid-Free Immunosuppression: Infectious Complications
    West-Thielke, P.
    Shields, A.
    Kaufman, D.
    Leone, J.
    Wiseman, A.
    Matas, A.
    Sa, T.
    King, E.
    Alloway, R.
    Woodle, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 383 - 384
  • [29] Renal Function Improvement in Early Conversion to Sirolimus with Similar Patient Survival and Metabolic Side Effects of Continued CNI Immunosuppression
    Silvera, Ana
    Sanchez, Concepcion
    Escobedo, Miguel
    Alarcon-Galvan, Gabriela
    Cordero, Paula
    Zapata, Homero A.
    Perez-Rodriguez, Edelmiro
    Guevara, Asdrubal
    Hernandez-Guedea, Marco A.
    Munoz, Linda E.
    HEPATOLOGY, 2015, 62 : 841A - 842A
  • [30] Conversion of liver transplant recipients with renal impairment to everolimus with CNI minimization or elimination: Six-month data from a multicenter, randomized trial
    de Simone, Paolo
    Metselaar, Harold J.
    Dumortier, Jerome
    Sterneck, Martina
    Rostaing, Lionel
    Giostra, Emiliano
    Varo, Evaristo
    Nevens, Frederic
    TRANSPLANT INTERNATIONAL, 2007, 20 : 32 - 32
12345